Differential effects of glucagon-like peptide-1 on microvascular recruitment and glucose metabolism in short- and long-term insulin resistance

被引:22
|
作者
Sjoberg, Kim A. [1 ]
Rattigan, Stephen [2 ]
Jeppesen, Jacob F. [1 ]
Lundsgaard, Anne-Marie [1 ]
Holst, Jens J. [3 ]
Kiens, Bente [1 ]
机构
[1] Univ Copenhagen, Dept Nutr Exercise & Sports, Fac Sci, Sect Mol Physiol,August Krogh Ctr, DK-2100 Copenhagen, Denmark
[2] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia
[3] Univ Copenhagen, Dept Biomed Sci, DK-2100 Copenhagen, Denmark
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2015年 / 593卷 / 09期
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
FREE FATTY-ACIDS; MUSCLE MICROVASCULATURE; GLYCEMIC CONTROL; HEALTHY-SUBJECTS; RECEPTOR KINASE; IN-VIVO; TYPE-2; GLP-1; SENSITIVITY; SECRETION;
D O I
10.1113/JP270129
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Acute infusion of glucagon-like peptide-1 (GLP-1) has potent effects on blood flow distribution through the microcirculation in healthy humans and rats. A high fat diet induces impairments in insulin-mediated microvascular recruitment (MVR) and muscle glucose uptake, and here we examined whether this could be reversed by GLP-1. Using contrast-enhanced ultrasound, microvascular recruitment was assessed by continuous real-time imaging of gas-filled microbubbles in the microcirculation after acute (5 days) and prolonged (8 weeks) high fat diet (HF)-induced insulin resistance in rats. A euglycaemic hyperinsulinaemic clamp (3 mU min(-1) kg(-1)), with or without a co-infusion of GLP-1 (100 pmol l(-1)), was performed in anaesthetized rats. Consumption of HF attenuated the insulin-mediated MVR in both 5 day and 8 week HF interventions which was associated with a 50% reduction in insulin-mediated glucose uptake compared to controls. Acute administration of GLP-1 restored the normal microvascular response by increasing the MVR after both 5 days and 8 weeks of HF intervention (P < 0.05). This effect of GLP-1 was associated with a restoration of both whole body insulin sensitivity and increased insulin-mediated glucose uptake in skeletal muscle by 90% (P < 0.05) after 5 days of HF but not after 8 weeks of HF. The present study demonstrates that GLP-1 increases MVR in rat skeletal muscle and can reverse early stages of high fat diet-induced insulin resistance in vivo.
引用
收藏
页码:2185 / 2198
页数:14
相关论文
共 50 条
  • [11] Glucagon-like peptide-1 and control of insulin secretion
    Thorens, B
    DIABETES & METABOLISM, 1995, 21 (05) : 311 - 318
  • [12] Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs
    Nishizawa, M
    Moore, MC
    Shiota, M
    Gustavson, SM
    Snead, WL
    Neal, DW
    Cherrington, AD
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (05): : E1027 - E1036
  • [13] Glucagon-like peptide-1, glucose homeostasis and diabetes
    Holst, Jens J.
    Deacon, Carolyn F.
    Vilsboll, Tina
    Krarup, Thure
    Madsbad, Sten
    TRENDS IN MOLECULAR MEDICINE, 2008, 14 (04) : 161 - 168
  • [14] Glucagon-Like Peptide-1: Glucose Homeostasis and Beyond
    Cho, Young Min
    Fujita, Yukihiro
    Kieffer, Timothy J.
    ANNUAL REVIEW OF PHYSIOLOGY, VOL 76, 2014, 76 : 535 - 559
  • [15] Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes
    El Bekay, Rajaa
    Coin-Araguez, Leticia
    Fernandez-Garcia, Diego
    Oliva-Olivera, Wilfredo
    Bernal-Lopez, Rosa
    Clemente-Postigo, Mercedes
    Delgado-Lista, Javier
    Diaz-Ruiz, Alberto
    Guzman-Ruiz, Rocio
    Vazquez-Martinez, Rafael
    Lhamyani, Said
    Mar Roca-Rodriguez, Maria
    Fernandez Veledo, Sonia
    Vendrell, Joan
    Malagon, Maria M.
    Jose Tinahones, Francisco
    BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (11) : 1820 - 1834
  • [16] Cellular glucose availability and glucagon-like peptide-1
    Park, Jae-Hyung
    Earm, Yung E.
    Song, Dae-Kyu
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2011, 107 (02): : 286 - 292
  • [17] Extrapancreatic effects of glucagon-like peptide-1
    Papazafiropoulou, A.
    Pappas, S.
    Papanas, N.
    ARCHIVES OF HELLENIC MEDICINE, 2014, 31 (06): : 686 - 692
  • [18] Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes
    Luque, MA
    González, N
    Márquez, L
    Acitores, A
    Redondo, A
    Morales, M
    Valverde, I
    Villanueva-Peñacarrillo, ML
    JOURNAL OF ENDOCRINOLOGY, 2002, 173 (03) : 465 - 473
  • [19] INFLUENCE OF GLUCAGON-LIKE PEPTIDE-1 ON SKELETAL MUSCLE MICROVASCULATURE AND INSULIN RESISTANCE
    Barrett, Eugene
    Chai, Weidong
    Dong, Zhenhua
    Suburan, Sharmila
    Liu, Zhenqi
    JOURNAL OF VASCULAR RESEARCH, 2015, 52 : 3 - 4
  • [20] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805